Characterization of a cDNA for rhesus monkey protein C inhibitor--evidence for N-terminal involvement in heparin stimulation.
cDNAs for protein C inhibitor (PCI) were cloned from human and rhesus monkey liver RNAs by reverse transcription and polymerase chain reaction (PCR) amplification. Sequencing showed that rhesus monkey and human PCI cDNAs were 93% identical. Predicted amino acid sequences differed at 26 of 387 residues. Four of these differences (T352M, N359S, R362K, L363I) were in the reactive center loop that is important for inhibitory specificity, and two were in the N-terminal helix (M8T, E13K) that is implicated in glycosaminoglycan binding. PCI in human or rhesus monkey plasma showed comparable inhibitory activity towards human activated protein C in the presence of 10 U/ml heparin. However, maximal acceleration of the inhibition of activated protein C required 5-fold lower heparin concentration for rhesus monkey than for human plasma, consistent with the interpretation that the additional positive charge (E13K) in a putative-heparin binding region increased the affinity for heparin.
Radtke
K P
KP
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.
Fernández
J A
JA
Villoutreix
B O
BO
Greengard
J S
JS
Griffin
J H
JH
D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D018076:DNA, Complementary / Q000235:genetics* / Q000302:isolation & purification; D006493:Heparin / Q000378:metabolism*; D006801:Humans; D008253:Macaca mulatta; D008958:Models, Molecular; D008969:Molecular Sequence Data; D018046:Protein C Inhibitor / Q000235:genetics* / Q000378:metabolism; D016415:Sequence Alignment; D017421:Sequence Analysis
D018076:DNA, Complementary; D018046:Protein C Inhibitor; D006493:Heparin